QuidelOrtho director receives 6,829-share stock award

QuidelOrtho Corp director Joseph D. Wilkins Jr. reported equity compensation activity involving 6,829 shares.

Rhea-AI Filing Summary

QuidelOrtho Corp director Joseph D. Wilkins Jr. reported equity compensation activity involving 6,829 shares. He received 6,829 shares of common stock on May 29, 2026 through the release of previously granted restricted stock units, with no sales reported. Following these transactions, he directly owns 18,705 shares of QuidelOrtho common stock. The filing also shows the corresponding exercise of 6,829 restricted stock units into common shares, with no remaining units from this grant after vesting.

Insider Trade Summary

6,829 shares exercised/converted

Exercise 2 txns

Insider Wilkins Joseph D Jr.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (Equity Grant)	6,829	$0.00	$0.00
Grant/Award	Common Stock	6,829	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 0 contracts (Direct); Common Stock — 18,705 shares (Direct)

Footnotes (3)

1. F1. Reflects release of restricted stock units that were previously reported on a Form 4.
2. F2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
3. F3. The restricted stock units vested on May 29, 2026.

Key Figures

Common shares acquired: 6,829 shares RSUs exercised: 6,829 units Shares after transaction: 18,705 shares +2 more

5 metrics

Common shares acquired 6,829 shares Grant/award acquisition on May 29, 2026

RSUs exercised 6,829 units Restricted stock units converted into common stock

Shares after transaction 18,705 shares Total common stock directly owned after Form 4

Exercise price $0.00 per share Conversion of restricted stock units to common stock

Transactions classified as acquisitions 2 transactions Both reported as acquire-direction entries on Form 4

Key Terms

Restricted Stock Units, restricted stock unit, vested, derivative security, +1 more

5 terms

Restricted Stock Units financial

"Reflects release of restricted stock units that were previously reported on a Form 4."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

restricted stock unit financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vested financial

"The restricted stock units vested on May 29, 2026."

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QuidelOrtho (QDEL) report for Joseph D. Wilkins Jr.?

QuidelOrtho reported that director Joseph D. Wilkins Jr. acquired 6,829 shares of common stock through the vesting of restricted stock units on May 29, 2026, with no shares sold in connection with this Form 4 filing.

How many QuidelOrtho (QDEL) shares does Joseph D. Wilkins Jr. hold after this Form 4?

After the reported transactions, Joseph D. Wilkins Jr. directly holds 18,705 shares of QuidelOrtho common stock. This total reflects the addition of 6,829 vested shares from restricted stock units, as disclosed in the Form 4.

Did the QuidelOrtho (QDEL) director sell any shares in this Form 4 filing?

No shares were sold. The Form 4 shows only acquisitions: a grant-related acquisition of 6,829 common shares tied to restricted stock unit vesting, and the corresponding exercise of those units into common stock, with no dispositions reported.

What do the 6,829 restricted stock units in the QuidelOrtho (QDEL) filing represent?

Each of the 6,829 restricted stock units represents the right to receive one share of QuidelOrtho common stock. The units vested on May 29, 2026, and were converted into 6,829 common shares as part of the reported transactions.

When did the restricted stock units for QuidelOrtho (QDEL) director vest?

The restricted stock units vested on May 29, 2026. On that date, 6,829 units previously reported in an earlier Form 4 were released and converted into an equal number of QuidelOrtho common shares for director Joseph D. Wilkins Jr.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkins Joseph D Jr.

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/29/2026		A		6,829(1)	A	$0	18,705	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Equity Grant)	(2)	05/29/2026		M			6,829	(3)	(3)	Common Stock	6,829	$0	0	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

3. The restricted stock units vested on May 29, 2026.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Joseph D. Wilkins, Jr.	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)